Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828678) titled 'PET/CT Imaging of GRPR Expression in Various Tumors' on Sept. 15.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Jewish General Hospital

Condition: Malignancies Multiple

Intervention: Diagnostic Test: GRPR PET/CT

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of First Enrollment: November 2026

Target Sample Size: 60

To know more, visit https://clinicaltrials.gov/study/NCT07828678

Published by HT Digital Content Services with permission from Health Daily Diges...